Innova Biosciences Ltd (Cambridge, UK), a leader in the field of bioconjugation, has been awarded €455,000 of a €3,000,000 European grant.
Innova Biosciences awarded EU grant to develop cancer biomarker discovery platform
Please download the press release below:
Babraham Bioscience Technologies Ltd (BBT) is responsible for the commercial development of the Babraham Research Campus. The Babraham Research Campus is distinct in its co-location of bioscience companies with the Babraham Institute, a world-renowned research organisation. The Campus provides companies laboratory and office space together with access to outstanding scientific facilities in an ideal geographical location at the core of the Cambridge cluster.